Alexion Pharmaceuticals, Inc. (ALXN) Tops Q1 EPS by 4c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alexion Pharmaceuticals (ALXN) Fundamentals Strong - Analyst
April 25, 2013 2:07 PM EDTWells Fargo today maintained a Market Perform rating on Alexion Pharmaceuticals (NASDAQ: ALXN). This morning Alexion reported Q1 results.
Commenting on the results, analyst Brian Abrahams said, "Q1 results were mostly inline with our expectation, though the raise in guidance should provide some... More
